Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Other Non-Current Liabilities (2016 - 2022)

Historic Other Non-Current Liabilities for vTv Therapeutics (VTVT) over the last 9 years, with Q1 2022 value amounting to $770000.0.

  • vTv Therapeutics' Other Non-Current Liabilities rose 144000.0% to $770000.0 in Q1 2022 from the same period last year, while for Mar 2022 it was $770000.0, marking a year-over-year increase of 144000.0%. This contributed to the annual value of $1.3 million for FY2021, which is 242400.0% up from last year.
  • Latest data reveals that vTv Therapeutics reported Other Non-Current Liabilities of $770000.0 as of Q1 2022, which was up 144000.0% from $1.3 million recorded in Q4 2021.
  • vTv Therapeutics' Other Non-Current Liabilities' 5-year high stood at $1.3 million during Q4 2021, with a 5-year trough of $50000.0 in Q4 2020.
  • In the last 5 years, vTv Therapeutics' Other Non-Current Liabilities had a median value of $258000.0 in 2018 and averaged $276294.1.
  • In the last 5 years, vTv Therapeutics' Other Non-Current Liabilities tumbled by 8076.92% in 2020 and then soared by 242400.0% in 2021.
  • vTv Therapeutics' Other Non-Current Liabilities (Quarter) stood at $260000.0 in 2018, then changed by 0.0% to $260000.0 in 2019, then crashed by 80.77% to $50000.0 in 2020, then surged by 2424.0% to $1.3 million in 2021, then tumbled by 38.99% to $770000.0 in 2022.
  • Its Other Non-Current Liabilities stands at $770000.0 for Q1 2022, versus $1.3 million for Q4 2021 and $50000.0 for Q3 2021.